University of Michigan ( Site 0003) — Ann Arbor, Michigan

Public research footprint of University of Michigan ( Site 0003), compiled from the ClinicalTrials.gov public registry.

5,080

Registered studies

1,388

Active

734

Recruiting now

2,892

Completed

684

Stopped or withdrawn

Most-studied conditions

Lung Non-Small Cell Squamous Carcinoma · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Stage IV Breast Cancer AJCC v6 and v7 · Clinical Stage II Esophageal Adenocarcinoma AJCC v8

Recently updated registry entries

NCT07161999 — Study of COYA 302 for the Treatment of ALS (Recruiting)
NCT07023627 — A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… (Recruiting)
NCT06203600 — Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Michigan ( Site 0003)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.